Home › NCT06983496
Pharmacist-Intensivist Collaborative Telehealth for Post-Intensive Care Syndrome
Pharmacist-Intensivist Collaborative Telehealth for Post-Intensive Care Syndrome in Survivors of Critical Illness: a Pilot Randomized Controlled Trial
Who can join
Ages 18 to 89 · All sexes
Full eligibility criteria
Inclusion Criteria: * Adults 18-89 years of age * Required admission to either medical or surgical ICU * Respiratory failure requiring invasive mechanical ventilation of at least 24 hours during ICU stay; or ICU stay of at least 7 days * Anticipated discharge to home after hospitalization * Consent from patients themselves or a legally authorized representative if necessary Exclusion Criteria: * Pregnancy * Incarceration/Imprisonment * Life expectancy less than 6 months or enrolled in hospice/palliative care * Anticipated discharge to skilled nursing facility, medical rehabilitation facility, or other long terms care facility * Unable to participate in telehealth
About the study
The goal of this pilot randomized controlled trial is to determine if a randomized controlled trial of a collaborative pharmacist-intensivist telehealth follow-up after intensive care unit discharge can feasibly be performed in patients who have survived a critical illness.
The study intervention will be telehealth follow-up appointments provided by clinical pharmacists at approximately one and three months post-hospital discharge. The purpose of the follow-up appointments will be to assess for post-intensive care syndrome and provide recommend interventions aimed at improving recovery
Participants will randomized to receive the study intervention or standard of care.
What is being tested
- Post-ICU Telehealth Follow-up (behavioral)
Sponsor: Malcom Randall VA Medical Center · Participants: 24 · Started: Jun 1, 2025
Contact the study team
- Andrew J Franck, Pharm.D. · Phone: 3523761611
Official record on ClinicalTrials.gov — NCT06983496
Locations in the U.S.
| Florida | Malcom Randall Veterans Affairs Medical Center, Gainesville |
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.